Published in J Clin Endocrinol Metab on May 01, 1998
Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors : comparison between micro- and macroadenomas. Am J Pathol (2000) 0.87
Comparisons between macroadenomas and microadenomas in Cushing's disease: characteristics of hormone secretion and clinical outcomes. J Korean Med Sci (2009) 0.81
Modulatory effect of BclI GR gene polymorphisms on the obesity phenotype in Brazilian patients with Cushing's disease. Clinics (Sao Paulo) (2013) 0.78
Expression and functional analysis of dopamine receptor subtype 2 and somatostatin receptor subtypes in canine cushing's disease. Endocrinology (2008) 0.78
Further arguments for a functional difference between pituitary corticotroph macroadenomas and microadenomas. J Clin Endocrinol Metab (1999) 0.76
Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre. Eur J Endocrinol (2016) 0.75
Bilateral inferior petrosal sinus sampling using vasopressin. Indian J Endocrinol Metab (2016) 0.75
Is there a role for early chemotherapy in the management of pituitary adenomas? Neuro Oncol (2016) 0.75
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology (1992) 9.30
Objective estimates of the probability of death from burn injuries. N Engl J Med (1998) 5.56
Carpal tunnel release. A prospective, randomized assessment of open and endoscopic methods. J Bone Joint Surg Am (1993) 5.04
Sample-size formula for the proportional-hazards regression model. Biometrics (1983) 5.00
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology (2004) 4.00
Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. N Engl J Med (2001) 3.78
The human Y chromosome: a 43-interval map based on naturally occurring deletions. Science (1992) 3.09
Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol (1997) 2.84
A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma. Cancer (1985) 2.82
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Eating disorders. N Engl J Med (1999) 2.77
Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics (1982) 2.74
Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol (1991) 2.70
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
Lateral geniculate nucleus in glaucoma. Am J Ophthalmol (1993) 2.55
National patterns of physician activities related to obesity management. Arch Fam Med (2000) 2.54
A pilot study of low-dose zidovudine in human immunodeficiency virus infection. N Engl J Med (1990) 2.48
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry (2000) 2.41
Ultrastructural localization of glial fibrillary acidic protein in mouse cerebellum by immunoperoxidase labeling. J Cell Biol (1977) 2.39
Neutrophil action dysfunction and abnormal neutrophil behavior. N Engl J Med (1974) 2.35
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis. Neurology (2003) 2.10
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol (2000) 1.93
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.91
The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab (1999) 1.89
A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab (1996) 1.85
Properties of proportional-hazards score tests under misspecified regression models. Biometrics (1984) 1.84
Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol (1999) 1.81
High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res (2000) 1.80
Infantile neuroaxonal dystrophy. A disease characterized by altered terminal axons and synaptic endings. Neurology (1968) 1.80
Generation of mammalian cells stably expressing multiple genes at predetermined levels. Anal Biochem (2000) 1.79
Analysing survival in the presence of an auxiliary variable. Stat Med (1994) 1.75
Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med (2000) 1.74
The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience (2010) 1.69
Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.68
The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab (1995) 1.64
Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials. Stat Med (1993) 1.62
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab (1989) 1.61
Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the copper/zinc superoxide dismutase gene. Ann Neurol (1998) 1.59
Osteopenia in men with a history of delayed puberty. N Engl J Med (1992) 1.59
Combining mortality and longitudinal measures in clinical trials. Stat Med (1999) 1.56
Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old. Int Psychogeriatr (1998) 1.56
Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.54
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
HCC patients suffer less from geographic differences in organ availability. Am J Transplant (2013) 1.52
Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg (1997) 1.52
Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord (2000) 1.49
Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science (1981) 1.48
Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol (1984) 1.47
Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. J Neurosurg (1999) 1.46
Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res (1991) 1.46
Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology (1989) 1.46
Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J Clin Invest (2001) 1.45
Significant reductions in mortality for children with burn injuries through the use of prompt eschar excision. Ann Surg (1988) 1.45
Mapping of cytochrome oxidase patches and ocular dominance columns in human visual cortex. Philos Trans R Soc Lond B Biol Sci (1984) 1.45
Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke (1990) 1.44
Adult onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol (2008) 1.40
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
Design considerations for AIDS trials. N Engl J Med (1990) 1.38
Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol (1983) 1.36
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med (1994) 1.36
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med (1996) 1.34
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab (1992) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med (2000) 1.33
Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury. J Neuropathol Exp Neurol (1999) 1.33
Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol (2000) 1.33
Prompt eschar excision: a treatment system contributing to reduced burn mortality. A statistical evaluation of burn care at the Massachusetts General Hospital (1974-1984). Ann Surg (1986) 1.32
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab (2004) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA (1998) 1.30
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg (1992) 1.28
Consequence of ligation of the vertebral artery. J Neurosurg (1972) 1.27
Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg (1991) 1.27
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2006) 1.27
Idiopathic spinal cord herniation: a treatable cause of the Brown-Sequard syndrome--case report. Neurosurgery (1995) 1.27
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
A consensus on the diagnosis and treatment of acromegaly complications. Pituitary (2013) 1.26
Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. Am J Clin Nutr (1997) 1.26
Distribution of cholesterol-1,2-H3 during maturation of mouse peripheral nerve. Lab Invest (1969) 1.26